Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 EMBASE search strategy

From: Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis

1 exp mass screening/
2 limit 1 to (human and english language)
3 screen*.mp.
4 limit 3 to (human and english language)
5 exp “cost benefit analysis”/ or exp “cost effectiveness analysis”/ or cost-effective*.mp.
6 limit 5 to (human and english language)
7 2 or 4
8 6 and 7